M. Hazra, “A rational pharmacovigilance safety appraisal of topical pefloxacin 0.3% ophthalmological drops in bacterial conjunctivitis, in global multi-centre tertiary care hospitals”, Int J Basic Clin Pharmacol, vol. 11, no. 4, pp. 302–307, Jul. 2022.